Point-of-care coagulation management in intensive care medicine. 2013

Patrick Meybohm, and Kai Zacharowski, and Christian F Weber

UI MeSH Term Description Entries
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D003422 Critical Care Health care provided to a critically ill patient during a medical emergency or crisis. Intensive Care,Intensive Care, Surgical,Surgical Intensive Care,Care, Critical,Care, Intensive,Care, Surgical Intensive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D019095 Point-of-Care Systems Laboratory and other services provided to patients at the bedside. These include diagnostic and laboratory testing using automated information entry. Bedside Computing,Point of Care Technology,Bedside Technology,Point-of-Care,Bedside Technologies,Computing, Bedside,Point of Care,Point of Care Systems,Point-of-Care System,Systems, Point-of-Care,Technologies, Bedside,Technology, Bedside
D019468 Disease Management A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596) Disease Managements,Management, Disease,Managements, Disease

Related Publications

Patrick Meybohm, and Kai Zacharowski, and Christian F Weber
January 1996, Seminars in thrombosis and hemostasis,
Patrick Meybohm, and Kai Zacharowski, and Christian F Weber
November 2011, Medizinische Klinik, Intensivmedizin und Notfallmedizin,
Patrick Meybohm, and Kai Zacharowski, and Christian F Weber
July 2020, Sensors (Basel, Switzerland),
Patrick Meybohm, and Kai Zacharowski, and Christian F Weber
October 2018, Romanian journal of anaesthesia and intensive care,
Patrick Meybohm, and Kai Zacharowski, and Christian F Weber
February 2018, Deutsche medizinische Wochenschrift (1946),
Patrick Meybohm, and Kai Zacharowski, and Christian F Weber
January 2022, Minerva anestesiologica,
Patrick Meybohm, and Kai Zacharowski, and Christian F Weber
September 2019, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine,
Patrick Meybohm, and Kai Zacharowski, and Christian F Weber
February 2013, Current opinion in anaesthesiology,
Patrick Meybohm, and Kai Zacharowski, and Christian F Weber
February 2014, Der Anaesthesist,
Patrick Meybohm, and Kai Zacharowski, and Christian F Weber
September 2013, Medizinische Klinik, Intensivmedizin und Notfallmedizin,
Copied contents to your clipboard!